Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease - Barschke, Peggy; Abu-Rumeileh, Samir; Al Shweiki, M. H. D. Rami; Barba, Lorenzo; Paolini Paoletti, Federico; Oeckl, Patrick; Steinacker, Petra; Halbgebauer, Steffen; Gaetani, Lorenzo; Lewerenz, Jan; Ludolph, Albert Christian; Landwehrmeyer, Georg Bernhard; et al. (Journal of neurology, 2022)
Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; Atrophy; Biomarkers; Cerebrospinal fluid; Dopamine receptors; Huntington's disease; Huntingtons disease; Liquid chromatography; Mass spectroscopy; Medicine; Medicine & Public Health; Movement disorders; Neostriatum; Neurodegeneration; Neurodegenerative diseases; Neurology; Neuroradiology; Neurosciences; Parkinson's disease; Patients; Peptides; Pharmacodynamics; Prodynorphin; Proenkephalin; Short; Short Commentary; Biomarkers; Endogenous opioids; Huntington’s disease; Cerebrospinal fluid; Mass spectrometry; Parkinson’s disease